4
Registered trials
3
Recruiting
4
Unique sponsors
4
Unique IMPs
1
Commercial trials
Drug classes (ATC)
L
Oncology (ATC L)
1
—
ATC code not specified
2
C
Cardiology (ATC C)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
3 substances
Colony-stimulating factor
1 substance
Phase II:
3
Phase I/II:
1
Phase II
3 trials-
EndedCHRU De Nancy AcademicIMP not specified
-
RecruitingUniversitaetsklinikum Aachen AöR AcademicINTESTIFIX
-
RecruitingUniversity Hospital Of Clermont-Ferrand AcademicCARVEDILOL
Phase I/II
1 trial-
RecruitingResolution Therapeutics Limited CommercialFILGRASTIM; RTX001
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Resolution Therapeutics Limited | Commercial | 1 | Phase I/II | 1 |
| CHRU De Nancy | Academic | 1 | Phase II | 0 |
| Universitaetsklinikum Aachen AöR | Academic | 1 | Phase II | 1 |
| University Hospital Of Clermont-Ferrand | Academic | 1 | Phase II | 1 |
New trials by year
2022
1
2025
3